+
Site Tour

ESOC 2023: Meet the Expert: My AF patient will not undergo occlusion of the LAA

Meet The Expert Session: A case-based debate: Which patients might benefit from left atrial appendage occlusion? Hans-Christoph Diener discusses a patient case study.

Related Videos

ESOC 2023: LAAO case

LAAO Summit - New data & future trials

LAAO Summit - Pre-procedural imaging

PremiClose 2024: Neo-Ped Cardio Team

Patent Foramen Ovale Patient Management

Premiclose 2022: Midterm evolution of PDA closure

LAAO Summit - Sealing the appendage

LAAO Summit - Debate: Factor XI inhibitors

Webinar PFO closure in patients >60 Years

TRENDING TOPICS

Abbott TMTI at PCRLV - recorded cases and more

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation | PCR LV '24

Abbott TMTI sponsored symposium at PCRLV 2024

Unlocking the potential of mitral and tricuspid valves clipping | PCR London Valves 2024

Amplatzer™ Amulet™ LAA Occluder

Why Amulet™ LAAO: A Case-Based Review with top experts

A. Shah, D. Shah, O.de Backer

CONNEXT


HUB
RELATED RESOURCES

Clinical insights: LAAO

ESOC presentation: PFO closure in patients > 60 Years

PDL Technical Analysis by Dr. Lakkiredy

Clinical insights: Amulet™

CONNEXT


LIVE
RELATED EVENTS

Navigating the Anatomy | Mitral focus

LAAO Summit - LAAO in a patient at risk of DRT

LAAO Summit 2023: Live Case: Frankfurt

SAFETY IS A JOURNEY | M. Swaans & G. Leurent

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline